Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Enterprise Value (2016 - 2025)

Nutex Health's Enterprise Value history spans 16 years, with the latest figure at -$91.9 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 694.55% year-over-year to -$91.9 million; the TTM value through Dec 2025 reached -$91.9 million, down 694.55%, while the annual FY2025 figure was -$91.9 million, 694.55% down from the prior year.
  • Enterprise Value for Q4 2025 was -$91.9 million at Nutex Health, down from -$45.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $40.8 million in Q4 2021 and bottomed at -$91.9 million in Q4 2025.
  • The 5-year median for Enterprise Value is -$15.4 million (2022), against an average of -$17.3 million.
  • The largest YoY upside for Enterprise Value was 151640.68% in 2021 against a maximum downside of 105448.72% in 2021.
  • A 5-year view of Enterprise Value shows it stood at $40.8 million in 2021, then tumbled by 123.99% to -$9.8 million in 2022, then surged by 55.58% to -$4.3 million in 2023, then skyrocketed by 455.34% to $15.5 million in 2024, then tumbled by 694.55% to -$91.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Enterprise Value are -$91.9 million (Q4 2025), -$45.2 million (Q3 2025), and $4.9 million (Q2 2025).